Search - tctmd.com

Displaying 41 - 60 of 362

Sort: Relevancy | Date

News Conference News AHA 2024

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Caitlin E. Cox

November 21, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

Presenter: Patrick Serruys

October 30, 2024

Presentation TCT 2024

TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI

Presenter: Young-Kwan Kim

October 30, 2024

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

Presentation TCT 2024

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Presenter: Naomi Hamburg

October 29, 2024

Presentation TCT 2024

Lipid-Lowering Therapies for High-Risk Patients: Act Early and Target Aggressively

Presenter: Marc Bonaca

October 28, 2024

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Todd Neale

October 10, 2024

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Conference News SCCT 2024

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Todd Neale

July 24, 2024

News Daily News

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Michael O'Riordan

July 23, 2024

Advertisement

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Lipid-Lowering Therapies for High-Risk Patients: Act Early and Target Aggressively

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content